Monthly Archives: June 2016

Biotech BD Transactions: The Soft Stuff
June 27, 2016

This blog was written by Samantha Truex, former CBO of Padlock Therapeutics, as part of the From The Trenches feature of LifeSciVC. I grew up in a setting where “continuous improvement” and “total quality management” were household terms, as unusual

1 Comment

I/O: The Strategic Supernova In Cancer Today
June 22, 2016

With the big cancer confab ASCO 2016 fading into memory, R&D teams everywhere are getting back to work on their cancer programs – and across the industry many of them will be doing the same work, on the same targets,

3 Comments

Life In The Trenches Of A Biotech LLC
June 21, 2016

This blog was written by Jeb Keiper, CBO of Nimbus Therapeutics LLC, as part of the From The Trenches feature of LifeSciVC. Unsurprisingly, I had not given that much thought to the parent entity of my new employer when I

2 Comments

Digital Health in Clinical Trials
June 9, 2016

This blog was written by Adam Rosenberg, CEO of Rodin Therapeutics, as part of the From The Trenches feature of LifeSciVC. As a controlled experiment, try placing a tape recorder, rotary phone or record album in front of an 8

Leave a comment

Growth Phase: Avoiding Vertigo During the Ride Up
June 6, 2016

This blog was written by Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC Startup life can be grueling.  It’s an especially gratifying feeling when your data and your investors signal that it’s

Leave a comment

The White House’s National Microbiome Initiative: My Reflections
June 2, 2016

This blog was written by JC Gutierrez-Ramos, CEO of Synlogic, as part of the From The Trenches feature of LifeSciVC.   Despite being central to life on earth, we know little about how microbes interact with each other, their hosts and

1 Comment